Kyp Systems, Inc
KYP SYSTEMS TAKES ON THE CHALLENGE OF UPCOMING 2009 PHRMA CODE
Wednesday 10 December 2008
*Editor’s note: Samples available upon request CONTACT: Anne Donohoe / Charlotte Maumus KCSA Strategic Communications (212) 896-1261 / (212) 896-1269 adonohoe@kcsa.com / cmaumus@kcsa.com Company Answering Need of Pharmaceutical Marketing Industry Due to New PhRMA Marketing Regulations NEW YORK, December 10, 2008 – Pharmaceutical marketers are getting ahead of the 2009 PhRMA code with the help of Kyp Systems, a unique marketing company whose Integrated Engagement solutions have been generating unprecedented response rates in the sector. The company has helped brands including AstraZeneca, Roche Pharmaceuticals, GlaxoSmithKline, Merck, and Bayer connect with audiences. “The combination of emerging media trends and the new regulation coming out of PhRMA, the industry trade and lobbying organization, has increased the need for our innovative solutions,” said Lou Vastardis, vice president of business development, Kyp Systems, Inc. “Beginning in 2009, the new PhRMA code prohibits the distribution of any promotional item that is not 100 percent education focused. Currently, the use of promotional items to reach physicians and patients represents $2 billion a year in marketing spend. As a company that specializes in creating marketing vehicles that educate and empower individuals, we are well equipped to help pharmaceutical companies enhance e-detailing, compliance, and patient care initiative while complying with the 2009 PhRMA code.’’ The company’s primary solution platform, called the iKyp, is a customizable, paper-based interactive marketing medium consisting of expanding inserts and informative knowledge wheels. As a portable and dynamic early engagement tool, the iKyp delivers information in a way that is easily digested, used and retained by recipients. Able to be integrated into a variety of channel applications, including in-office, direct mail, magazine insert, and events, the patented marketing tool is generating unprecedented response and engagement results for the pharmaceutical industry. In order to further integrate its solutions and create deeper learning experiences through digital media, Kyp Systems developed the iKyp webkey. This patented, plug and play device delivers a unique code that connects recipients to online destinations while creating progressive web experiences. Rather than simply herding people to a Web site, iKyp webkey solutions provide entirely new engagement experiences that educate audiences offline and then guide them through individually tailored experiences online. “This blending of physical print-based media with proprietary technology creates a highly effective engagement experience,” said Nicholas Miller, CEO, Kyp Systems, Inc. “By educating and empowering audiences our solutions are generating unprecedented results, as demonstrated by the 20 percent total response rate we achieved for AstraZeneca through a turnkey direct mail application that connects physicians to a protected brand Web site.” For more information about Kyp Systems’ pharmaceutical solutions, call 800-549-0104 or email pharma-info@iKyp.com. About Kyp Systems, Inc. iKyp is a trademark of Kyp Systems. All other names are the property of their respective owners. # # # KYP SYSTEMS TAKES ON THE CHALLENGE OF UPCOMING 2009 PHRMA CODE
Kyp Systems, Inc. is the U.S. division of Kyp Systems Plc, the creator and exclusive producer of the patented iKyp. Launched in September 2005, the iKyp is a customizable, paper-based marketing tool that is proven to generate higher ROI and response rates. Globally headquartered in London, the company’s North American headquarters are in New York, with operations in China and the Middle East.